Successful Treatment of Immunoblastic Lymphadenopathy-Like T-cell Lymphoma with Cyclosporin A

References

• Frizzera G., Moran E. M., Rappaport H. Angio-immunoblastic lymphadenopathy with dysprotein-aemia. Loncet 1974; 1070–1073, i
   PubMed Web of Science ®Google Scholar
• Lukes R. J., Tindle B. H. Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin's disease. New England Journal of Medicine 1975; 292: 1–8
   PubMed Web of Science ®Google Scholar
• Shimoyama M., Minato K., Saito H., Takenaka T., Watanabe S., Nagatani T., Naruto M. Immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma. Japanese Journal of Clinical Oncology 1979; 9%(Suppl.)347–356
   Google Scholar
• Tobinai K., Minato K., Ohtsu T., Mukai K., Kagami Y., Miwa M., Watanabe S., Shimoyama M. Clini-copathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma. Blood 1988; 72: 1000–1006
   PubMed Web of Science ®Google Scholar
• Watanabe S., Sato Y., Shimoyama M., Minato K., Shimosato Y. Immunoblastic lymphadenopathy, angio-immunoblastic lymphadenopathy, and IBL-like T-cell lymphoma: a spectrum of T-cell neoplasia. Cancer 1986; 58: 2224–2232
   PubMed Web of Science ®Google Scholar
• Murayama T., Imoto S., Takahashi T., Ito M., Matozaki S., Nakagawa T. Successful treatment of angioim-munoblastic lymphadenopathy with dysproteinemia with cyclosporin A. Cancer 1992; 69: 2567–2570
   PubMed Web of Science ®Google Scholar
• Theodorou I., Raphagl M., Bigorgne C., Fourcade C., Lahet C., Cochet G., Lefranc M. -P., Gaulard P., Farcet J. -P. Recombination pattern of the TCR y locus in human peripheral T-cell lymphomas. Journal of Pathology 1994; 174: 233–242
   PubMed Web of Science ®Google Scholar
• Sigal N. H., Dumont F. J. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annual Review of. Immunology 1992; 10: 519–560
   Web of Science ®Google Scholar
• Schreiber S. L., Crabtree G. R. The mechanism of action of cyclosporin A and FK506. Immunology Today 1992; 13: 136–142
   PubMedGoogle Scholar
• Kahan B. D. Immunosuppressive agents acting upon lymphokine synthesis and signal transduction. Clinical Transplantation 1993; 7: 113–125
   Web of Science ®Google Scholar
• Hess A. D. Cellular immunobiology of cyclosporin A. In Immunosuppressive drugs: developments in anti-rejection therapy, A. W. Thompson, T. Starzl. Edward Arnold. 1994; 47–62, London
   Google Scholar
• Reem G. H., Cook L. A., Vilĉek J. Gamma inter-feron synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. Science 1983; 221: 63–65
   PubMed Web of Science ®Google Scholar
• Andersson J., Nagy S., Groth C. -G., Andersson U. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 1992; 15: 136–142
   Google Scholar
• Costello R., Mawas C., Olive D. Differential immuno-suppressive effects of metabolic inhibitors on T-lymphocyte activation. European Cyrokine Network 1993; 4: 139–146
   PubMed Web of Science ®Google Scholar
• Han C. -W., Imamura M., Hashino S., Zhu X., Tanaka J., Imai K., Matsudaira T., Asano S. Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression. Bone Marrow Transplantation 1995; 15: 733–739
   PubMed Web of Science ®Google Scholar
• Fukuzawa M., Shearer GM. Effect of cyclosporin A on T cell immunity: I. Dose-dependent suppression of different murine T helper cell pathways. European Journal of Immunology 1989; 19: 49–56
   PubMed Web of Science ®Google Scholar
• Wheeler D. J., Robins A., Pritchard D. I., Bundick R. V., Shakib F. Potentiation of in vitro synthesis of human IgE by cyclosporin A (CsA). Clinical and Experimentol Immunology 1995; 102: 85–90
   PubMed Web of Science ®Google Scholar
• Bundick R. V., Craggs R. I., Holness E. The effect of cyclosporin A, FK506, and rapamycin on the murine chronic graft-versus-host response - an in vivo model of Th2-like activity. Clinical and Experimental Immunology 1995; 99: 467–472
   PubMed Web of Science ®Google Scholar
• Ohnishi K., Ichikawa A., Kagami Y., Nagasaka T., Niwa T., Hotta T., Saito H. Interleukin 4 and y-inter-feron may play a role in the histopathogenesis of peripheral T-cell lymphoma. Cancer Research 1990; 50: 8028–8033
   PubMed Web of Science ®Google Scholar
• Men H., Fliedner A., Orscheschek K., Binder Th., Sebald W., Müller-Hermelink H. K., Feller A. C. Cytokine expression in T-cell lymphomas and Hodgkin's disease. American Journal of Pathology 1991; 139: 1173–1180
   PubMedGoogle Scholar
• Hsu S. -M., Waldron J. A., Fink L., King C., Xie S. -S., Mansouri A., Barlogie B. Pathogenic significance of interleukin-6 in angioimmunoblastic lymphadenop-athy-type T-cell lymphoma. Human Parhology 1993; 24: 126–131
   PubMed Web of Science ®Google Scholar
• Kato H., Nagasaka T., Ichikawa A., Kinoshita T., Murate T., Tsushita K., Hotta T., Saito H. Tumor necrosis factor-b˜ gene expression and its relationship to the clinical features and histopathogenesis of peripheral T-cell lymphomas. Leukemia and Lymphoma 1994; 16: 125–133
   PubMed Web of Science ®Google Scholar
• Foss H. -D., Anagnostopoulos I., Herbst H., Grebe M., Zie-Mann K., Hummel M., Stein H. Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1995; 85: 2862–2869
   PubMed Web of Science ®Google Scholar
• Takeshita M., Sumiyoshi Y., Masuda Y., Ohshima K., Yoshida T., Kikuchi M., Müller H. Cytokine (interleukin-I alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma. Pathology, Research and Practice 1993; 189: 18–25
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84: 4008–4027
   PubMed Web of Science ®Google Scholar
• Kita H., Ohnishi T., Okubo Y., Weiler D., Abrams J. S., Gleich G. J. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. Journal of Experimental Medicine 1991; 174: 745–748
   PubMed Web of Science ®Google Scholar
• Cirillo R., Triggiani M, Siri L., Ciccarelli A., Pettit G. R., Condorelli M., Marone G. Cyclosporin A rap idly inhibits mediator release from human basophils presumably by interacting with cyclophilin. Journal of Immunology 1990; 144: 3891–3897
   PubMed Web of Science ®Google Scholar
• Hatfield S. M., Roehm N. W. Cyclosporine and FK506 inhibition of murine mast cell cytokine production. Journal of Pharmacology and Experimental Therapeutics 1992; 260: 680–688
   PubMed Web of Science ®Google Scholar
• Ito C., Ribeiro R. C., Behm F. G., Raimondi S. C., hi C. -H., Campana D. Cyclosporin A induces apop-tosis in childhood acute lymphoblastic leukemia cells. Blood 1998; 91: 1001–1007
   PubMed Web of Science ®Google Scholar